-
Originally Posted by Sparky4444
So I am wondering if this means RepliCel will be going to market SOONER in Asia as the result of this??? Phase II in EU for 2014 means we're not looking for this until 2015 IF we're lucky
It was never speculated to be out before 2015. Aderans was supposed to be available in 2014 but because they couldn't get their sh*t together for funding, the whole project got put in limbo.
2015 is only possible in Asia... though with our luck, I have a feeling it won't happen until 2016 or later.
-
I was just browsing through the website and read the pdf provided to investors. It says on the main page that the trials will start in the first half of 2014 and run through 2015. In the presentation for investors, it says they hope to collect and analyze phase 2 data in 2016...
If anything, 2017 is most likely for a release .. and even that's a little optimistic seeing how things have been "progressing".
-
I've never got my hopes up for this joke of a product...2017, forget that noise...there'll be a cure by then ...what a hopeless project this RepliCel is
-
New Regenerative Medicine Legislation Passed in Japan
On November 20, 2013 the Japanese Legislature approved new legislation targeted at improving the development and regulatory processes for regenerative medicine therapies. The Regenerative Medicine Law directs the Ministry of Health, Labour and Welfare to adopt new procedures and rules that will accelerate the clinical development of regenerative medicine and cell therapies. The Japanese Pharmaceutical Affairs Law will now become the Pharmaceuticals and Medical Devices Act that will include a new branch specifically for Regenerative Medicine Products, which will be regulated on a fast track process that focuses primarily on product safety. Under the law, the government is responsible for mapping out and implementing measures to safely accelerate research and development projects and make regenerative medicine widely available in the country. The law specifically stipulates that the government must make basic plans for the promotion of regenerative medicine and change such plans if necessary by reviewing them at least every three years in light of any changes in external conditions that may occur. This news positively impacts RepliCel and its licensing partner, Shiseido, as it looks to conduct human clinical trials on RCH-01.
This is the part to be actually happy about. This will speed any potential stem cell treatment and among them is the technique of Tsuji lab, when they start their human clinical trial. So...
-
More News
http://www.replicel.com/replicel-rec...on-technology/
They do indeed seem to be marching forward in terms of developing the company. Let's hope the new trials show results.
-
...wtf with more trials?? They did phase II trials two years ago, just about now...They know by now if that crap works or it doesn't...the fact they need to do more trials means the technology is a joke
-
Similar Threads
-
By lurker77 in forum Replicel
Replies: 44
Last Post: 12-19-2014, 02:34 PM
-
By TravisB in forum Cutting Edge / Future Treatments
Replies: 7
Last Post: 07-12-2013, 03:39 PM
-
By asianvolume13 in forum Men's Hair Loss: Start Your Own Topic
Replies: 0
Last Post: 12-25-2010, 06:12 AM
-
By joe from staten island in forum Introduce Yourself & Share Your Story
Replies: 0
Last Post: 07-28-2009, 10:38 AM
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules
|
» IAHRS
» The Bald Truth
» americanhairloss.org
|
Bookmarks